The farnesoid X receptor negatively regulates osteoclastogenesis in bone remodeling and pathological bone loss.
Saved in:
| Title: | The farnesoid X receptor negatively regulates osteoclastogenesis in bone remodeling and pathological bone loss. |
|---|---|
| Authors: | Zheng T; College of Pharmacy, Sookmyung Women's University, Yongsan-ku, Seoul, Republic of Korea., Kang JH; College of Pharmacy, Sookmyung Women's University, Yongsan-ku, Seoul, Republic of Korea., Sim JS; College of Pharmacy, Sookmyung Women's University, Yongsan-ku, Seoul, Republic of Korea., Kim JW; Department of Pharmacology and Dental Therapeutics, Research Center for Biomineralization Disorders, School of Dentistry, Chonnam National University, Gwangju, Republic of Korea., Koh JT; Department of Pharmacology and Dental Therapeutics, Research Center for Biomineralization Disorders, School of Dentistry, Chonnam National University, Gwangju, Republic of Korea., Shin CS; Department of Internal Medicine, College of Medicine, Seoul National University, Seoul, Republic of Korea., Lim H; Departments of Physics, Hunter College of the City University of New York, New York City, New York, USA., Yim M; College of Pharmacy, Sookmyung Women's University, Yongsan-ku, Seoul, Republic of Korea. |
| Source: | Oncotarget [Oncotarget] 2017 Aug 28; Vol. 8 (44), pp. 76558-76573. Date of Electronic Publication: 2017 Aug 28 (Print Publication: 2017). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
